Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Rofecoxib ineffective as adjuvant treatment for colorectal cancer

NEW YORK (Reuters Health) – Rofecoxib used as adjuvant therapy does not improve survival or reduce recurrences in patients who have undergone surgery for colorectal cancer, according to final results of the abbreviated Vioxx in Colorectal Cancer Therapy: Definition of Optimal Regime (VICTOR) trial...

Reuters Health • The Doctor's Channel Daily Newscast

Screening high-risk patients catches pancreatic cancer at resectable stage

NEW YORK (Reuters Health) – Patients at high risk for pancreatic cancer can be effectively screened with imaging studies and genetic testing, allowing curable neoplasm to be identified and resected, researchers report in Clinical Cancer Research for October 15. Dr. Harold Frucht of Columbia University...

Reuters Health • The Doctor's Channel Daily Newscast

Interferon, vitamins do not improve efficacy of BCG for bladder cancer

NEW YORK (Reuters Health) – Adding interferon alpha-2b and megadose vitamins to treatment with intravesical BCG does not improve outcomes in patients with non-muscle invasive bladder cancer. In fact, it only seems to make side effects worse, according to a study reported in November’s Journal of Urology...